AAAAAA

   
Results: 1-9 |
Results: 9
PHASE-II TRIAL OF THE USE OF MODIFIED BEP (BLEOMYCIN-B, ETOPOSIDE-E, CISPLATIN-P) AS A FIRST LINE TREATMENT OF ULTRA-HIGH-RISK (UHR) GESTATIONAL TROPHOBLASTIC TUMORS (GTT)
Authors: MURAD AM GUIMARAES RC ARAGAO BC SCALABRININETO AO
Citation: Am. Murad et al., PHASE-II TRIAL OF THE USE OF MODIFIED BEP (BLEOMYCIN-B, ETOPOSIDE-E, CISPLATIN-P) AS A FIRST LINE TREATMENT OF ULTRA-HIGH-RISK (UHR) GESTATIONAL TROPHOBLASTIC TUMORS (GTT), Annals of oncology, 9, 1998, pp. 325-325
PHARMACOECONOMIC EVALUATION OF TEGAFUR-URACIL (UFT) VS FLUOROURACIL FOR THE MANAGEMENT OF COLORECTAL-CANCER IN BRAZIL AND ARGENTINA
Authors: MURAD AM DEANDRADE CA DELFINO C ARIKIAN S DOYLE JJ DEZII CM SADANA A SINHA N
Citation: Am. Murad et al., PHARMACOECONOMIC EVALUATION OF TEGAFUR-URACIL (UFT) VS FLUOROURACIL FOR THE MANAGEMENT OF COLORECTAL-CANCER IN BRAZIL AND ARGENTINA, Clinical drug investigation, 13(2), 1997, pp. 90-98
PHASE-II MULTICENTRIC TRIAL OF THE USE OF INTRAVENOUS CLODRONATE BY SINGLE 15 DAY INTERVAL INFUSIONS IN PATIENTS WITH BONE OSTEOLYSIS
Authors: MURAD AM ANDRADE ACC SANTOS MO DELGADO G MOURA CE HUNGRIA V CHIATTONE C DEGUSMAO CB MARQUES E
Citation: Am. Murad et al., PHASE-II MULTICENTRIC TRIAL OF THE USE OF INTRAVENOUS CLODRONATE BY SINGLE 15 DAY INTERVAL INFUSIONS IN PATIENTS WITH BONE OSTEOLYSIS, European journal of cancer, 33, 1997, pp. 252-252
PHASE-II MULTICENTRIC TRIAL OF NEOADJUVANT BLEOMYCIN, IFOSFAMIDE AND CARBOPLATIN (BIC) IN LOCALLY ADVANCED CERVICAL-CANCER
Authors: MURAD AM TRIGINELLI SA GUIMARAES RC ARAGAO BC GONCALVES OX LIMA LC
Citation: Am. Murad et al., PHASE-II MULTICENTRIC TRIAL OF NEOADJUVANT BLEOMYCIN, IFOSFAMIDE AND CARBOPLATIN (BIC) IN LOCALLY ADVANCED CERVICAL-CANCER, European journal of cancer, 33, 1997, pp. 930-930
PACLITAXEL(T) PLUS 5-FLUOROURACIL (5-FU) - A NOVEL AND VERY ACTIVE REGIMEN FOR ADVANCED GASTRIC-CANCER (AGC) - A PHASE-II TRIAL
Authors: MURAD AM GUIMARAES RC ARAGAO BC FERREIRA AF SCHWARTSMANN G BRUNDANI A
Citation: Am. Murad et al., PACLITAXEL(T) PLUS 5-FLUOROURACIL (5-FU) - A NOVEL AND VERY ACTIVE REGIMEN FOR ADVANCED GASTRIC-CANCER (AGC) - A PHASE-II TRIAL, European journal of cancer, 33, 1997, pp. 1255-1255
PHASE-II TRIAL OF PACLITAXEL AND IFOSFAMIDE AS A SALVAGE TREATMENT INMETASTATIC BREAST-CANCER
Authors: MURAD AM GUIMARAES RC AMORIM WC MORICI AC FERREIRAFILHO AF SCHWARTSMANN G
Citation: Am. Murad et al., PHASE-II TRIAL OF PACLITAXEL AND IFOSFAMIDE AS A SALVAGE TREATMENT INMETASTATIC BREAST-CANCER, Breast cancer research and treatment, 45(1), 1997, pp. 47-53
PHASE-II TRIAL OF ISOTRETINOIN AND INTERFERON ALPHA-2A IN THE TREATMENT OF ADVANCED RECURRENT CERVICAL-CARCINOMA
Authors: MURAD AM OLIVEIRA M SALDANHA TM
Citation: Am. Murad et al., PHASE-II TRIAL OF ISOTRETINOIN AND INTERFERON ALPHA-2A IN THE TREATMENT OF ADVANCED RECURRENT CERVICAL-CARCINOMA, International journal of gynecological cancer, 4(6), 1994, pp. 414-418
PHASE-II TRIAL OF BLEOMYCIN, IFOSFAMIDE, AND CARBOPLATIN IN METASTATIC CERVICAL-CANCER
Authors: MURAD AM TRIGINELLI SA RIBALTA JCL
Citation: Am. Murad et al., PHASE-II TRIAL OF BLEOMYCIN, IFOSFAMIDE, AND CARBOPLATIN IN METASTATIC CERVICAL-CANCER, Journal of clinical oncology, 12(1), 1994, pp. 55-59
MODIFIED THERAPY WITH 5-FLUOROURACIL, DOXORUBICIN, AND METHOTREXATE IN ADVANCED GASTRIC-CANCER
Authors: MURAD AM SANTIAGO FF PETROIANU A ROCHA PRS RODRIGUES MAG RAUSCH M
Citation: Am. Murad et al., MODIFIED THERAPY WITH 5-FLUOROURACIL, DOXORUBICIN, AND METHOTREXATE IN ADVANCED GASTRIC-CANCER, Cancer, 72(1), 1993, pp. 37-41
Risultati: 1-9 |